Date: 2016-08-04
Type of information: Construction of new premises
Compound: new manufacturing facility supplying RNA interference-based therapeutics
Company: Jacobs Engineering Groupe (USA - CA) Alnylam Therapeutics (USA - MA)
Therapeutic area: Technology - Services
Type agreement: construction of new premises services contract
Action mechanism:
Disease:
Details: * On August 4, 2016, Jacobs Engineering Group announced it was awarded a contract to provide engineering services and procurement for Alnylam Pharmaceuticals’ new manufacturing facility in Norton, Massachusetts .
Under the terms of the agreement, Jacobs is providing engineering services and procurement for the multi-product facility being built to supply RNA interference-based therapeutics for clinical and commercial needs. The 200,000 square foot facility is expected to be completed in 2018.
Financial terms:
Latest news:
